Medtronic reports first quarter fiscal 2027 results; delivers broad-based portfolio performance and raises fiscal 2027 guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Needham on Medtronic, Inc. (MDT): 'We believe that MDT is in the early stages of a strong product cycle'
September 1, 2026 1:27 PM EDTNeedham analyst Michael Matson reiterated a Buy rating and $114.00 price target on Medtronic, Inc. (NYSE: MDT).
The analyst comments "MDT's F1Q27 revenue and EPS beat consensus, and management raised FY27 revenue and EPS guidance. Organic growth improved to 7.0%... More
Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
September 1, 2026 6:47 AM EDTMedtronic (NYSE: MDT) reported Q1 EPS of $1.45, $0.06 better than the analyst estimate of $1.39. Revenue for the quarter came in at $9.8 billion versus the consensus estimate of $9.55 billion.
GUIDANCE:
Medtronic sees FY2027 EPS of $5.94-$6.00, versus the consensus of $5.95.
For earnings history and earnings-related data on Medtronic (MDT) click here.
... More